{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:56:02Z","timestamp":1787187362035,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["surgjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.surg.2016.06.065","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T11:15:54Z","timestamp":1478862954000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1\u2013related hyperparathyroidism"],"prefix":"10.1016","volume":"161","author":[{"given":"Angelica M.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Vodopivec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Christakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Waguespack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Petak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2016.06.065_bib1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2009.03672.x","article-title":"Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy","volume":"72","author":"Coutinho","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.surg.2016.06.065_bib2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.surg.2016.06.065_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","article-title":"Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy","volume":"134","author":"Burgess","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.surg.2016.06.065_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jocd.2012.11.003","article-title":"Hereditary hyperparathyroidism syndromes","volume":"16","author":"Giusti","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.surg.2016.06.065_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.surg.2016.06.065_bib6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2016.06.065_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.soc.2015.06.008","article-title":"Multiple endocrine neoplasia: genetics and clinical management","volume":"24","author":"Norton","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.surg.2016.06.065_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00268-014-2555-6","article-title":"Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"38","author":"Sharma","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2016.06.065_bib9","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2016.06.065_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archsurg.133.2.126","article-title":"The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1","volume":"133","author":"Burgess","year":"1998","journal-title":"Arch Surg"},{"key":"10.1016\/j.surg.2016.06.065_bib11","first-page":"729","article-title":"Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2016.06.065_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1530\/EJE-08-0153","article-title":"Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile","volume":"159","author":"Lourenco","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2016.06.065_bib13","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2016.06.065_bib14","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2016.06.065_bib15","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2016.06.065_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2004.01422.x","article-title":"Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features","volume":"257","author":"Bilezikian","year":"2005","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.surg.2016.06.065_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S8756-3282(99)00207-0","article-title":"Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study","volume":"25","author":"Christiansen","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.surg.2016.06.065_bib18","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00198-014-2689-2","article-title":"Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism","volume":"25","author":"Koumakis","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.surg.2016.06.065_bib19","series-title":"Epidemiology of primary hyperparathyroidism","author":"Robert","year":"2015"},{"key":"10.1016\/j.surg.2016.06.065_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.surg.2016.06.065_bib21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","article-title":"FRAX and its applications to clinical practice","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.surg.2016.06.065_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11914-010-0032-1","article-title":"The utility and limitations of FRAX: A US perspective","volume":"8","author":"Silverman","year":"2010","journal-title":"Curr Osteoporos Rep"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606016305207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606016305207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T16:26:16Z","timestamp":1536251176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606016305207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0039606016305207"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2016.06.065","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1\u2013related hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2016.06.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}